Literature DB >> 8536808

Thyroid function parameters during a selenium repletion/depletion study in phenylketonuric subjects.

M R Calomme1, J B Vanderpas, B François, M Van Caillie-Bertrand, A Herchuelz, N Vanovervelt, C Van Hoorebeke, D A Vanden Berghe.   

Abstract

Phenylketonuric (PKU) subjects have a limited supply of selenium (Se) in their phenylalanine-restricted diet. A Se repletion (1 microgram Se/kg/day)/depletion study was conducted in PKU children to determine the effect of Se on thyroid function parameters. The initial plasma Se concentration (mean +/- SD: 0.26 +/- 0.12 mumol/L, p < 0.00003, n = 10) and glutathione peroxidase (GSH-Px) activity (140 +/- 58 U/L, p < 0.00003, n = 10) were significantly lower compared to age-matched controls. After 14 weeks of supplementation, the plasma Se concentration (mean +/- SD: 0.74 +/- 0.20 mumol/L) normalized (normal range: 0.57-1.15 mumol/L, mean +/- SD: 0.76 +/- 0.13 mumol/L, n = 32) and remained stable thereafter during repletion. Plasma GSH-Px activity reached normal values after 18 weeks of supplementation (312 +/- 57 U/L; normal range: 238-492 U/L, mean +/- SD: 345 +/- 54 U/L, n = 32) and increased significantly for up to eight weeks thereafter (332 +/- 52 U/L). Individual and mean thyroid parameters were initially normal in all cases. The mean concentrations of plasma thyroxine (T4: p < 0.025), free T4 (FT4: p < 0.01) and reverse triiodothyronine (rT3: p < 0.005) decreased to 75% of their initial value within three weeks of Se supplementation and remained stable thereafter, within a normal physiological range during selenium supplementation. They increased back to their initial values three weeks (T4: p < 0.05, FT4: p < 0.05) and six weeks (rT3: p < 0.025) respectively, after the end of the supplementation. In conclusion, Se supplementation modifies thyroid function parameters in Se-deficient PKU subjects most likely by an increase in activity of type I 5'-deiodinase (5'-DIase I).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8536808     DOI: 10.1007/bf01944738

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  26 in total

1.  Identification of type I iodothyronine 5'-deiodinase as a selenoenzyme.

Authors:  D Behne; A Kyriakopoulos; H Meinhold; J Köhrle
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

2.  Potentially life-threatening cardiac dysrhythmia in a child with selenium deficiency and phenylketonuria.

Authors:  L G Greeves; D J Carson; B G Craig; D McMaster
Journal:  Acta Paediatr Scand       Date:  1990-12

3.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

Authors:  D E Paglia; W N Valentine
Journal:  J Lab Clin Med       Date:  1967-07

4.  Evidence that type II 5'-deiodinase is not a selenoprotein.

Authors:  M Safran; A P Farwell; J L Leonard
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

5.  Selenium deficiency triggering intractable seizures.

Authors:  V T Ramaekers; M Calomme; D Vanden Berghe; W Makropoulos
Journal:  Neuropediatrics       Date:  1994-08       Impact factor: 1.947

6.  Evidence that cysteine, not selenocysteine, is in the catalytic site of type II iodothyronine deiodinase.

Authors:  M J Berry; J D Kieffer; P R Larsen
Journal:  Endocrinology       Date:  1991-07       Impact factor: 4.736

7.  Selenium intake of infants and young children, healthy children and dietetically treated patients with phenylketonuria.

Authors:  I Lombeck; K H Ebert; K Kasperek; L E Feinendegen; H J Bremer
Journal:  Eur J Pediatr       Date:  1984-12       Impact factor: 3.183

8.  Short-term dietary selenium restriction in young adults: quantitative studies with the stable isotope 74SeO3(2-).

Authors:  L J Kasper; V R Young; M Janghorbani
Journal:  Br J Nutr       Date:  1984-11       Impact factor: 3.718

9.  Seleno-lactobacillus. An organic selenium source.

Authors:  M Calomme; J Hu; K Van den Branden; D A Vanden Berghe
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

10.  Selenium requirements of rats for normal hepatic and thyroidal 5'-deiodinase (type I) activities.

Authors:  S Vadhanavikit; H E Ganther
Journal:  J Nutr       Date:  1993-06       Impact factor: 4.798

View more
  9 in total

1.  Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults.

Authors:  Gerald F Combs; Douglas N Midthune; Kristine Y Patterson; Wesley K Canfield; A David Hill; Orville A Levander; Philip R Taylor; James E Moler; Blossom H Patterson
Journal:  Am J Clin Nutr       Date:  2009-04-29       Impact factor: 7.045

2.  PLASMA PHENYLALANINE DETERMINATION BY QUANTITATIVE DENSITOMETRY OF THIN LAYER CHROMATOGRAMS AND BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY IN RELATION WITH MODERN MANAGEMENT OF PHENYLKETONURIA.

Authors:  C V Mihali; C M Petrescu; F C Ladaşiu-Ciolacu; I Mândruţiu; D Bechet; T Nistor; A Ardelean; Gh Benga
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Oct-Dec       Impact factor: 0.877

3.  COMPARISON OF PLASMA PHENYLALANINE DETERMINATION BY DENSITOMETRY OF THIN-LAYER CHROMATOGRAMS AND BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY IN RELATION WITH THE SCREENING OF PHENYLKETONURIA.

Authors:  C V Mihali; M C Petrescu; I Mândruţiu; D Bechet; T V Nistor; V Turcuş; A Ardelean; Gh Benga
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Apr-Jun       Impact factor: 0.877

4.  The role of selenium in iodine metabolism in children with goiter.

Authors:  P Zagrodzki; H Szmigiel; R Ratajczak; Z Szybinski; Z Zachwieja
Journal:  Environ Health Perspect       Date:  2000-01       Impact factor: 9.031

5.  Intake of partially defatted Brazil nut flour reduces serum cholesterol in hypercholesterolemic patients--a randomized controlled trial.

Authors:  Roberta F Carvalho; Grazielle V B Huguenin; Ronir R Luiz; Annie S B Moreira; Glaucia M M Oliveira; Glorimar Rosa
Journal:  Nutr J       Date:  2015-06-16       Impact factor: 3.271

Review 6.  Supplementation of Micronutrient Selenium in Metabolic Diseases: Its Role as an Antioxidant.

Authors:  Ning Wang; Hor-Yue Tan; Sha Li; Yu Xu; Wei Guo; Yibin Feng
Journal:  Oxid Med Cell Longev       Date:  2017-12-26       Impact factor: 6.543

7.  Thyroid hormone status in patients with severe selenium deficiency.

Authors:  Masanobu Kawai; Yasuko Shoji; Shinsuke Onuma; Yuri Etani; Shinobu Ida
Journal:  Clin Pediatr Endocrinol       Date:  2018-04-13

8.  Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis.

Authors:  Gina A Montoya Parra; Rani H Singh; Aysun Cetinyurek-Yavuz; Mirjam Kuhn; Anita MacDonald
Journal:  Orphanet J Rare Dis       Date:  2018-06-26       Impact factor: 4.123

9.  2022 European Thyroid Association Guideline for the management of pediatric Graves' disease.

Authors:  Christiaan F Mooij; Timothy D Cheetham; Frederik A Verburg; Anja Eckstein; Simon H Pearce; Juliane Léger; A S Paul van Trotsenburg
Journal:  Eur Thyroid J       Date:  2022-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.